The World Anti-Doping Agency (WADA) prohibits AOD-9604 as a non-approved substance and potential performance-enhancing agent in athletics, citing concerns about unfair advantage through lean body mass gains (if efficacious, which remains unproven)
More and more people who started taking the new GLP-1 agonist drugs are now confronting the realities of their limitations
Under no circumstances should any information, tools, or calculations presented on this site be taken as medical advice
Dont get your hair colored
Has been shown to slow the aging process of the reproductive system
Foundayo may suit people who: Prefer tablets to injections Want a once-daily GLP-1 option May find strict fasting instructions difficult Prefer a treatment that may fit more easily into daily life Are suitable after a clinical assessment Foundayo may be less suitable for people who: Are already taking another GLP-1 treatment Have been advised against GLP-1 medicines Have certain stomach, pancreas, gallbladder or thyroid-related medical history Are pregnant, breastfeeding or trying to conceive Need a treatment that is already available now Which oral GLP-1 tablet is better
